TY - JOUR
T1 - Transcription factor adrenal 4 binding protein as a marker of adrenocortical malignancy
AU - Sasano, Hironobu
AU - Shizawa, Souichirou
AU - Suzuki, Takashi
AU - Takayama, Kazuto
AU - Fukaya, Takao
AU - Morohashi, Kenichirou
AU - Nagura, Hiroshi
PY - 1995/10
Y1 - 1995/10
N2 - Adrenal 4 binding protein (Ad4BP) is a transcription factor that regulates the expression of the steroidogenic enzymes and is expressed primarily in steroidogenic cells. We immunolocalized Ad4BP in adrenocortical carcinoma (eight cases) and various malignancies that histologically simulate an adrenocortical carcinoma to evaluate the value of Ad4BP as an immunohistochemical marker of adrenocortical carcinoma. These malignancies examined were renal cell carcinoma (20 cases), hepatocellular carcinoma (10 cases), malignant melanoma (eight cases), ovarian (six cases) and uterine (three cases) clear cell carcinoma, large cell carcinoma of the lung (five cases), and pheochromocytoma (three cases). Nuclear Ad4BP immunoreactivity was observed only in adrenocortical carcinoma cases but not in other tumors examined. Almost all of the adrenocortical carcinoma cells were immunohistochemically positive for Ad4BP including cells associated with bizarre nuclei. These results show that application of Ad4BP immunostain can contribute greatly to the differential diagnosis of adrenocortical carcinoma.
AB - Adrenal 4 binding protein (Ad4BP) is a transcription factor that regulates the expression of the steroidogenic enzymes and is expressed primarily in steroidogenic cells. We immunolocalized Ad4BP in adrenocortical carcinoma (eight cases) and various malignancies that histologically simulate an adrenocortical carcinoma to evaluate the value of Ad4BP as an immunohistochemical marker of adrenocortical carcinoma. These malignancies examined were renal cell carcinoma (20 cases), hepatocellular carcinoma (10 cases), malignant melanoma (eight cases), ovarian (six cases) and uterine (three cases) clear cell carcinoma, large cell carcinoma of the lung (five cases), and pheochromocytoma (three cases). Nuclear Ad4BP immunoreactivity was observed only in adrenocortical carcinoma cases but not in other tumors examined. Almost all of the adrenocortical carcinoma cells were immunohistochemically positive for Ad4BP including cells associated with bizarre nuclei. These results show that application of Ad4BP immunostain can contribute greatly to the differential diagnosis of adrenocortical carcinoma.
KW - adrenal 4 binding protein
KW - adrenal cortex
KW - diagnosis
KW - immunohistochemistry
KW - transcription factor
UR - http://www.scopus.com/inward/record.url?scp=0029127128&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0029127128&partnerID=8YFLogxK
U2 - 10.1016/0046-8177(95)90280-5
DO - 10.1016/0046-8177(95)90280-5
M3 - Article
C2 - 7557951
AN - SCOPUS:0029127128
SN - 0046-8177
VL - 26
SP - 1154
EP - 1156
JO - Human Pathology
JF - Human Pathology
IS - 10
ER -